1956
). So far as the author has been able to ascertain, this is the first case in which the "albumin associated" insulin antagonist described by Vallance Owen, Dennes and Campbell (1958) has been estimated. It was present in normal amounts.
Case Report
Mr. F.S., aged 53, having suffered from alopecia totalis since the age of 35, was admitted on 29.11.61 with a four-month history of thirst, polyuria and weight loss (21 lbs.-9.6 kg.). He was mildly ketotic and dehydrated, but no other unusual feature was noted. There was no family history of diabetes. He was stabilised on 72 units of Lente Insulin and a 2,500 calorie diet and discharged. He was readmitted on 4.4.62, in an unstable diabetic state, complaining over the previous month of episodes of intermittent abdominal pain and vomiting associated with constipation.
On Examination the liver was noted to be two fingers' breadth enlarged, firm and smooth, and there was also epigastric tenderness. "Liver nails" were at this time noted. He was not pigmented. There (De Filippis and Iannaccone, 1952; Lowell, 1944) , and which bind insulin administered, causing it to move electrophorretically with the gamma globulins in the plasma, (Berson, Yalow, Bauman, Rothschild and Newerly, 1956 ). There appears to be a rough correlation between the titre of antibody present, and the degree of insulin resistance, (Berson and Yalow, 1959) , although this has not always been confirmed (Arquilla and Stavitski, 1956 (Wright, 1960) . Such antibodies have been demonstrated in cases of insulin resistance in association with a large number of totally unrelated conditions in otherwise healthy diabetics, 1962a) , and also in non-diabetic, otherwise healthy mental patients, undergoing insulin coma therapy (Banting, Frank and Gairns, 1938) . On two occasions they have been described in association with haemochromatosis, (Colwell and Weiger, 1956; Eskind, Franklin and Lowell, 1953 Consequently, in view of these facts and the remarks regarding the infrequency of insulin resistance in primary haemochromatosis quoted above, it appears unlikely that infiltration of the reticulo-endothelial system with iron is responsible for the development of antibodies.
Insulin resistance due to antibodies has been reported in association with hepatic fibrosis resulting from a number of causes (Olsen and Neutzel, 1950) . However, the infrequency and haphazard nature of its occurrence in such states makes it appear improbable that hepatic fibrosis per se is a cause of antibody formation. This is also true of other conditions which cause changes in the plasma protein pattern, such as myelomatosis, amyloidosis or nephrotic syndrome (Field, 1962a) . The fact that no grossly abnormal gamma globulin band was found may be related to the mildness of the resistance in this case; only 600 units of insulin were required daily to control the ketosis, whereas 11,000 were required by Colwell and Weiger's case, and as stated above there is probably a correlation between the titre of antibody and the degree of resistance.
It therefore appears from a review of work of others, that the insulin resistance which occurs in association with haemochromatosis is in no way directly related to the condition, except that the development of a diabetic state requires POSTGRADUATE MEDICAL JOURNAL September, 1965 the administration of exogenous insulin. Insulin resistance is probably no more liable to occur in diabetics with haemochromatosis than in diabetics suffering from idiopathic diabetes, either alone or in association with other disease processes.
The beneficial effects of corticosteroids and ACTH on insulin resistance where high antibody titres are present has been noted previously, (Field, 1962b; Oakley, Field, Sowton, Rigbyand Cunliffe, 1959) . The fall in insulin requirements in this particular case was dramatic, occurring within a few days. A similar fall occurred in Colwell and Weiger's case, and in those described by Oakley and others (op. cit.) . The mode of action of the corticosteroids is obscure, as the effect occurs before a fall in the antibody titre takes place, although this does occur within 10-14 days of the administration of corticosteroids. As mentioned above, however, not all cases of insulin resistance have high antibody titres, and it has been postulated some mechanism other than simple binding of insulin by the antibody takes place to account for at least some of the resistance. Field, Johnson and Herring (1961) suggest that this may be due to reduce tissue responsiveness. Relapse has -been known to occur in many cases treated by corticosteroids (Oakley and others, 1959) and may take up to eighteen months to develop. To the present date, a further relapse has not occurred in this case.
Finally, with regard to the normal serum iron biochemistry, it has recently been shown (Williams, Scheuer and Sherlock, 1963) in a familial study of haemochromatosis, that this condition may be present in a subclinical form for many years before the classical symptoms and signs develop. In these people, similar to the patient described here, the serum iron may be normal and the serum iron binding capacity unsaturated.
Summary and Conclusions
A case of insulin resistance in association with subclinical haemochromatosis is described. THE DANGERS of giving aspirin or antibiotics to patients on anticoagulant therapy are widely recognised. Aspirin and other salicylates which themselves produce a mild hypoprothromibinaemia are also gastric irritants. Gastrointestinal bleeding may follow the use of these drugs. The possible causes of such bleeding were reviewed by Watson and Pierson (1961) . Antibiotic therapy can affect anticoagulant control by interfering with the source of Vitamin K from the intestinal flora and thus indirectly affecting prothrombin production in the liver.
In addition to these there is a growing list of other drugs which potentiate anticoagulant therapy. Attention has recently been drawn to the reduced anticoagulant requirements of certain patients treated with Atromid, a preparation used to reduce serum triglyceride and cholesterol levels (Oliver, Roberts, Hayes, Partridge, Suzman and Bersohn, 1963) . A similar effect on anticoagulant therapy was noted by Winters and Soloff (1962) in a patient in whom hypercholesterolaemia was treated with D-thyroxine.
Other drugs reported to potentiate anticoagulant therapy were reviewed by Hellemans (1962) and include dinitrophenol, chlorpromazine, p-amino salicylic acid, testosterone, alcohol and probenecid. Quinine hydrochloride, chloroquine and hydroxychloroquine have also been reported as having an anticoagulant action (Mandel, 1962) and could therefore be expected to exert a synergistic effect on anticoagulant therapy. Kindermann (1961) reported two cases of spontaneous bleeding after combined therapy with phenindione and phenylbutazone (butazolidin) in the management of superficial thrombophlebitis; and earlier Humble (1953) had reported anomalies in blood clotting in patients on butazolidin. The purpose of this communication is to report a patient on anticoagulant therapy who showed marked prolongation of the prothrombin time and spontaneous bleeding some two weeks after beginning a course of the reliated compound oxyphenylbutazone (Tanderil).
Case Report
The patient, a printer, with known rheumatic heart disease and a history of angina for nine years, was aged 50 years when, in May 1960, he was admitted to hospital with a posterior myocardial infarct. He was discharged from hospital to continue on long term anticoagulant therapy with phenindione.
A year later in May 1961 he developed multiple small spontaneous bruises and a small subconjunctival haemorrhage, during the course of an upper respiratory tract infection with a productive cough.
The Quick one-stage prothrombin time was 3.2 times that of the control plasma (therapeutic range 2.0-2.5). Further slight spontaneous bruising occurred in May
